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Summary
The C57BL/6J mouse displays glucose intolerance and reduced insulin secretion. QTLmapping identified Nicotinamide Nu-
cleotide Transhydrogenase (Nnt), a nuclear-encoded mitochondrial protein thought to be involved in free radical detoxifica-
tion, as a candidate gene. To investigate its functional role, we used siRNA to knock downNnt in insulin-secretingMIN6 cells.
This produced a dramatic reduction in insulin secretion and the rise in [Ca2+]i evoked by glucose, but not tolbutamide. We
identified two ENU-induced point mutations in Nnt (N68K, G745D). Nnt mutant mice were glucose intolerant and secreted
less insulin during a glucose tolerance test. Isolated islets showed impaired insulin secretion in response to glucose, but
not to tolbutamide, and glucose failed to enhance ATP levels. Glucose utilization and production of reactive oxygen species
were increased inNnt b cells.We hypothesize thatNntmutations/deletion uncouple b cell mitochondrial metabolism leading
to less ATP production, enhanced KATP channel activity, and consequently impaired insulin secretion.
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Introduction
Type 2 diabetes mellitus is a serious metabolic disease that is
reaching epidemic proportions in Western societies and is pre-
dicted to affect 300 million people worldwide by 2025 (King
et al., 1998). Impaired glucose tolerance, which precedes diabe-
tes and is a risk factor for the disease, currently affects a further
200 million worldwide. Type 2 diabetes is characterized by ele-
vation of the blood glucose concentration, usually presents in
middle age, and is exacerbated by age and obesity. It is associ-
atedwith both impaired insulin secretion and insulin action, but it
is now recognized that b cell dysfunction is a key element in the
development of the disease (Bell and Polonsky, 2001; Kahn,
2003; Ashcroft and Rorsman, 2004).
Mouse models of diabetes and glucose intolerance may pro-
vide useful insights into insulin secretory mechanisms and the
etiology of human type 2 diabetes. One such example is the
C57BL/6J mouse strain, which shows impaired glucose toler-
ance under free-fed and postprandial conditions: using an intra-
peritoneal glucose tolerance test (IPGTT), the blood glucose
level of nonobese C57BL/6J mice rises higher and takes longer
to regain the resting level than that of other mouse strains (Kaku
et al., 1988; Rossmeisl et al., 2003; Kulkarni et al., 2003; Toye
et al., 2005). This is associated with reduced plasma insulin lev-
els, resulting from impaired first and second phase insulin re-
lease (Kaku et al., 1988; Rossmeisl et al., 2003; Kooptiwut
et al., 2002; Kayo et al., 2000). These effects are magnified in
mice that possess a genetic defect in insulin resistance (Kulkarni
et al., 2003). In addition, C57BL/6Jmice develop obesity, hyper-
glycemia, and insulin resistance when fed a high-fat diet (Ross-
meisl et al., 2003).
Insulin secretion from the b cells of the pancreatic islets is crit-
ically dependent on cellular ATP levels generated by glucose-
stimulated mitochondrial metabolism (Maechler and Wollheim,
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in insulin release via metabolic regulation of the activity of the
ATP-sensitive potassium (KATP) channel (Ashcroft and Rorsman
1989, 2004) (Figure 1). At low blood glucose levels, KATP chan-
nels are open, hyperpolarizing the b cell membrane and prevent-
ing Ca2+ influx and insulin secretion. When glucose levels rise,
increased b cell metabolism produces elevation of cellular
ATP levels. This causes closure of KATP channels, which leads
to membrane depolarization, activation of voltage-gated Ca2+
channels, Ca2+ entry, and a rise in [Ca2+]i that triggers insulin
secretion.
Earlier studies have shown that the reduced insulin secretion
of C57BL/6J mice derives from the failure of glucose to close
pancreatic b cell KATP channels (Toye et al., 2005). Conse-
quently, themembrane potential is not depolarized andCa2+ en-
try is prevented. However, the sensitivity of KATP channels in
C57BL/6J mice to inhibition by ATP (IC50 = 10 mM; Toye et al.,
2005) is similar to that observed for NMRI mice (Ashcroft and
Kakei, 1989) and for cloned b cell KATP channels expressed in
heterologous systems (Tucker et al., 1997). This suggests that
the defect in C57BL/6J mice lies prior to KATP channel closure,
probably at the level of b cell metabolism (Toye et al., 2005).
By intercrossing nonobese C57BL/6J andC3H/HeHmice and
employing QTL mapping, we identified three main genetic loci
that influence the difference in glucose homeostasis (Toye
et al., 2005). These were located on chromosomes 9, 11, and
13. Within the chromosome 13 locus lay the gene encoding Nic-
otinamide Nucleotide Transhydrogenase (Nnt), and sequencing
of the coding region of Nnt in C57BL/6J mice identified two mu-
tations (Toye et al., 2005). The first is a missense mutation
(M35T) in the mitochondrial leader sequence of the Nnt precur-
sor protein. The second is an in-frame 5-exon deletion that re-
moves four predicted transmembrane helices and their con-
necting linkers.
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A R T I C L ENnt is a nuclear-encodedmitochondrial protein that is located
in the inner mitochondrial membrane of eukaryotes and in the
plasma membrane of some bacteria (for review, see Hoek and
Rydstrom, 1988). It functions as a redox-driven proton pump,
catalyzing the reversible reduction of NADP+ by NADH and con-
version of NADH to NAD+. This is linked to proton translocation
across the membrane according to the reaction:
NADH+NADP+ + Hcytosolic4NAD
+ + NADPH+Hmatrix
Under physiological conditions, amarked proton gradient is present
across the inner mitochondrial membrane so that the reaction is
driven strongly to the right. This makes Nnt a very efficient generator
of NADPH. Moreover, it couples the production of NADPH to the
rate of mitochondrial metabolism, and hence to the production of
reactive oxygen species (ROS) generated by the electron transport
chain. Thus, Nnt is postulated to play an important role in the detox-
ification of ROS (Hoek and Rydstrom, 1988; Arkblad et al., 2005).
Nnt is a homodimer and the individual subunits (Mrw110 kDa)
are composed of three domains (Hoek and Rydstrom, 1988).
The N-terminal hydrophilic domain (I) binds NAD(H), the central
hydrophobic domain (II) intercalates into the membrane (it con-
sists of 14 transmembrane domains and forms the proton chan-
nel), and the C-terminal hydrophilic domain (III) binds NADP(H)
(Yamaguchi and Hatefi, 1991). Both domains I and III are located
within themitochondrial matrix. The 5-exon deletion found in the
Nnt gene of C57BL/6J mice deletes part of domain I and the first
four transmembrane domains and leads to amarked downregu-
lation of Nnt mRNA in liver and islets (Toye et al., 2005).
In this paper, we explore the functional role of Nnt in detail. We
show that knockdown ofNnt in insulin-secreting MIN6 cells pre-
vents elevation of intracellular calcium and insulin secretion in
response to glucose, but not to the KATP channel blocker tolbu-
tamide. Likewise, mice carrying mutations in Nnt have impaired
glucose tolerance and loss of both glucose-dependent insulin
secretion and ATP production in isolated pancreatic islets. In
addition, we found that mutant Nnt b cells show enhanced glu-
cose utilization and ROS production in response to glucose,
Figure 1. Mechanism of insulin secretion from pancreatic b cells
Under resting conditions, KATP channels are open, producing hyperpolarization of
the b cell plasma membrane and so preventing insulin secretion. Glucose uptake
(via the GLUT2 transporter) and its subsequent metabolism elevates ATP and re-
duces MgADP levels, causing KATP channels to close. This produces a membrane
depolarization that activates voltage-gated Ca2+ channels, causing Ca2+ influx and
a rise in cytosolic Ca2+ that triggers release of insulin granules. ATP also stimulates
the secretory machinery directly.
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RA36compared to wild-type b cells. Our data are consistent with
the idea that impaired Nnt function reduces b cell metabolism,
thereby preventing closure of KATP channels in response to glu-
cose, calcium influx, and insulin secretion.
Results
siRNA knockdown of Nnt in MIN6 cells
To determine the functional role of Nnt in b cells, we used siRNA
to silenceNnt in the insulin-secreting b cell line MIN6. MIN6 cells
were mock-transfected or transfected with one of four different
siRNA duplexes: nonsense, glucokinase (Gck), or two different
Nnt-specific siRNAs. Gck was used as positive control, as it is
a key glycolytic enzyme, and in its absence, insulin secretion
is abolished (Terauchi et al., 1995). A scrambled (nonsense)
siRNA was used as a negative control. We used two separate
Nnt siRNAs targeted to different regions of the gene. All siRNAs
were tagged with a fluorescent probe to enable transfected cells
to be easily detected.
Quantitative real-time PCR andWestern blotting were used to
verify mRNA and protein knockdown. Expression of Gck and
Nnt mRNAs was abolished by siRNAs targeted against these
genes, but neither was affected in cells transfected with non-
sense siRNA (Figure 2A). Similar results were found for protein
expression. Figure 2B shows Western blots of MIN6 cells
probed with antibodies to Gck and Nnt following transfection
with one of the three different siRNA. Islets isolated from C3H/
HeH and C57BL/6J mice are also included as positive and neg-
ative controls, respectively. The Nnt protein is not found in
C57BL/6J mice, although as previously reported, the RNA is
present (Toye et al., 2005). It is also clear that Nnt is present in
MIN6 cells transfected with nonsense (upper panels) or Gck
siRNA (lower panels) but not in cells transfected with Nnt siRNA
(middle panels). Transfection withGck siRNA abolished expres-
sion of Gck without altering Nnt expression (Figure 2B, lower
panels). A second Nnt siRNA also abolished protein and RNA
expression (data not shown). Thus, we achieved target-specific
knockdown of Nnt with both siRNAs.
Insulin secretion in MIN6 cells
We next compared insulin secretion fromMIN6 cells transfected
with nonsense siRNA or Nnt siRNA. Figure 2C shows that basal
insulin secretion in glucose-free solutionwas almost identical for
both nonsense andNnt siRNA-transfected cells but that glucose
failed to stimulate insulin secretion from cells in which Nnt had
been knocked down. However, the sulphonylurea tolbutamide
(200 mM) elicited equivalent responses in both nonsense and
Nnt siRNA-transfected cells. Because tolbutamide closes KATP
channels directly, this result suggests that the defect in insulin
secretion lies prior to KATP channel closure. Under our con-
ditions, about 95% of cells were transfected, as evidenced
by their fluorescence. This explains why knockdown of Nnt
was able to almost completely abolish insulin secretion in our
preparation.
Calcium imaging in MIN6 cells
To determine the cause of impaired insulin secretion, we mea-
sured changes in the intracellular calcium concentration
([Ca2+]i) of MIN6 cells evoked by glucose. In mock-transfected
cells, glucose concentrations greater than 2 mM elicited a rise
in [Ca2+]i (Figures 3A and 3C). This response was unaltered by
CT
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Nnt and insulin secretionFigure 2. Effect ofNnt knockdown on insulin release
from MIN6 cells
A) Comparative levels of Gck (top) and Nnt (bottom)
gene expression using quantitative PCR in MIN6
cells transfected with nonsense siRNA (ns control,
gray bar), Nnt siRNA (white bar), and Gck siRNA
(black bar). The data are the mean6 SD of five dupli-
cates and are representative of three separate ex-
periments.
B) Western blots of C3H/HeH (C3H) or C57BL/6J
(B6) mouse islets (left two lanes) and of MIN6 cells
(right lanes) transfected with nonsense siRNA (top),
Nnt siRNA (middle), orGck siRNA (bottom). NS, non-
sense-transfected MIN6 cells for comparison. Num-
bered lanes, number of MIN6 repeats of transfected
cells. Each blot was probed with three different anti-
bodies (Ab), as indicated on the left, against Nnt,
Gck, and actin (loading control, data not shown).
The data are representative of seven separate ex-
periments.
C) Insulin secretion in response to glucose (0, 2, 10
mM) or tolbutamide (200 mM) from MIN6 cells trans-
fected with nonsense siRNA (white bars, n = 6) or
with Nnt siRNA (black bars, n = 6). The data are the




Dtransfection with nonsense siRNA but was abolished by Gck
siRNA and markedly reduced by both Nnt siRNAs (Figures 3B
and 3C). These results resemble those found for C57BL/6J
mice (Toye et al., 2005) and demonstrate that the failure of glu-
cose to induce insulin secretion produced by downregulation of
Nnt is due to the inability of glucose to promote Ca2+ influx. Tol-
butamide (200mM), however, stimulated a similar increase in
[Ca2+]i in both cells transfected with nonsense and Nnt siRNA
(Figure 3D). The simplest explanation of these results is that glu-
cose fails to close KATP channels when Nnt is down regulated.
Nnt mutant mice show glucose intolerance
and reduced insulin secretion
We identified two mutant alleles of Nnt by screening the Harwell
ENU-DNA archive (Quwailid et al., 2004). The first (N68K) was an
exchange of C for A (nt 204) in exon 2 that results in a nonconser-
vative missense asparagine to lysine mutation at amino acid 68
of the protein. This mutation is located in the predicted NAD
binding domain of Nnt. The secondmutation (G745D) was found
in the membrane spanning domain of Nnt and consisted of an
exchange of G for A (nt 2224) in exon 14, resulting in a noncon-
servative substitution of glycine by aspartic acid at amino acid
RE
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species (Figure 4A).
Both mutants were recovered as live mice by IVF (male F1
BALB/c 3 C3H/HeH sperm and C3H/HeH eggs), and the prog-
eny were intercrossed to producemice homozygous for themu-
tations. Intraperitoneal glucose tolerance tests (IPGTT) revealed
that mice heterozygous and homozygous for the N68Kmutation
were markedly less glucose tolerant than their wild-type litter-
mates (Figure 5A). During a 2 hr IPGTT, blood glucose levels
rose significantly higher and took longer to return to baseline
in homozygous 12-week-old male mice. Furthermore, heterozy-
gotes were not as glucose intolerant as homozygotes (Figure
5A). These differences in glucose tolerance persisted at 16
weeks (Figure 5C). Both heterozygous and homozygous N68K
mice also secreted substantially less insulin over a 30min period
following a glucose challenge (Figure 5E). Very similar results
were obtained for femalemice (see Supplemental Data available
with this article online).
Figure 5B shows that 12-week-old male mice heterozygous
and homozygous for the G745Dmutation were also significantly
less glucose tolerant than controls during a 2 hr IPGTT. Interest-
ingly, the glucose tolerance profiles over 2 hr are very similar
for heterozygous and homozygous mice, suggesting that the37
A R T I C L EFigure 3. Effect of Nnt knockdown on Ca2+ transi-
ents in MIN6 cells
A) Representative changes in intracellular Ca2+,
measured by Fura-2 fluorescence, in response to
glucose and tolbutamide in single MIN6 cells. Bars
indicate when glucose (2, 5, 10mMglucose) or tolbu-
tamide (200 mM, Tol) were applied. Each color repre-
sents a different cell.
B) Representative changes in [Ca2+]i, measured by
Fura-2 fluorescence, in response to glucose and tol-
butamide in single MIN6 cells transfected with Cy3-
conjugated siRNA duplexes for NntI or NntII. Bars
indicate when glucose (2, 5, 10mMglucose) or tolbu-
tamide (200 mM, Tol) were applied. Each color repre-
sents a different cell.
C)Mean change in [Ca2+]i, in response to 2, 5, and 10
mM glucose, normalized to the resting [Ca2+]i, in
0 mM glucose for mock-transfected (orange) MIN6
cells or MIN6 cells transfected with nonsense
(blue), NntI (green), NntII (cyan), or Gck (pink) siRNA.
Each data point is the mean 6 SEM of 15–21 cells.
The data are representative of five separate experi-
ments.
D)Mean change in [Ca2+]i, in response to 200 mM tol-
butamide for MIN6 cells mock-transfected (orange)
or transfected with nonsense (blue), NntI (green),
NntII (cyan) or Gck (pink) siRNA. The data indicate
the mean 6 SEM of 15-21 cells. The data are repre-
sentative of 5 separate experiments.
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DG745D mutation affects heterozygous mice as severely as ho-
mozygous mice. Insulin secretion and glucose tolerance over
30 min were also impaired in 16-week-old mice (Figures 5D
and 5F). Similar results were found for G745D mutant female
mice (see Supplemental Data). Thus, two separate mutations
in the Nnt gene confer impaired glucose tolerance and insulin
responses. No difference in thermoregulation was observed for
either Nnt mutation (see Supplemental Data).
Nnt expression in Nnt mice
Western blotting was used to determine if Nnt mutant mice ex-
press the Nnt protein. Figure 4B shows that Nnt was expressed
in islets of homozygous N68K and G745D Nnt mice; therefore,
these mutations must affect protein function and/or mitochon-
drial membrane targeting.
Insulin secretion in Nnt mice islets
We nextmeasured insulin secretion from islets isolated fromNnt
mutant mice. Insulin secretion was normalized to insulin content
to control for any differences in islet size. There was no signifi-
cant difference in insulin content betweenwild-type ormutant is-
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gous or heterozygous G745D islets was not significantly
different from that of wild-type islets, but glucose (10 mM) stim-
ulated insulin secretion was substantially reduced. However, the
ability of tolbutamide to stimulate secretion was similar in all
three types of mice (Figure 6A). Similar results were obtained
for islets isolated from heterozygous or homozygous N68K
mice (data not shown). These results resemble those found for
MIN6 cells and suggest that both Nnt mutations produce
a loss of protein function.
ATP measurements in Nnt mice islets
The data reported here, and those found for C57BL/6J mice
(Toye et al., 2005), are consistent with the idea that Nnt deletion
or mutation impairs b cell metabolism and thereby insulin secre-
tion.We therefore measured ATP concentration in islets isolated
from wild-type, heterozygous and homozygous Nnt mutant
mice. As Figure 6B shows, ATP content increased significantly
(1.8-fold; p < 0.01) in wild-type islets when glucose was in-
creased from 2–20 mM. However, no increase was detected
in either heterozygous or homozygous G745D Nnt islets (FigureCELL METABOLISM : JANUARY 2006
Nnt and insulin secretionFigure 4. Identification of Nnt mutations
A) Alignment of Nnt amino acid sequence for various
species across the regions in which mutations in Nnt
were identified by screening the Harwell ENU-DNA
archive. The mutated amino acids in exon 2 (N68K)
and exon 14 (G745D) are indicated.
B)Western blots of islets isolated from homozygous
N68K or G745D Nnt mutant mice. Each blot was
probed with antibodies (Ab) against Nnt and actin,
as indicated. The data are representative of four sep-
arate experiments.6B). No significant difference was observed in resting ATP con-
tent (at 2 mM glucose). Similar results were obtained for N68K
islets (data not shown).
Reactive oxygen species measurements
Several studies have suggested that Nnt is involved in detoxifi-
cation of reactive oxygen species (ROS) generated by the elec-
tron transport chain (reviewed by Hoek and Rydstrom, 1988).
We thereforemeasured ROS production in single b cells isolated
from wild-type and homozygous Nnt G745D mice, using the
fluorescent dye 20,7’-dichlorofluorescein (Figure 6C). ROS pro-
duction was not significantly different in the absence of glucose
between wild-type and mutant b cells. Glucose (20 mM) pro-
duced a small increase (3-fold) in ROS production in wild-type
b cells, but a far more dramatic (w10-fold) increase in Nnt
G745D mouse b cells (Figure 6C).
Glucose utilization by Nnt mice islets
It has been shown that ROS increase the activity of uncoupling
proteins, such as UCP2 (Echtay et al., 2002; Krauss et al., 2003;
Brand et al., 2004). This leads to enhanced proton leakage
across the inner mitochondrial membrane, which reduces the
electromotive force and thereby ATP generation. Thus a possi-
ble explanation for the lower ATP production of Nnt G745D
mouse islets observed in 20 mM glucose is that it results from
mitochondrial uncoupling elicited by the greater levels of ROS.
To test this idea, we measured glucose utilization. As Figure
6D shows, glucose utilization in response to 20 mM glucose
was greater in islets isolated from homozygous Nnt G745D
mice than wild-type mice, whereas ATP production was lower.
This result is characteristic of an uncoupler (Green et al., 2004)
and suggests that at high glucose levels, mitochondria in Nnt
G745D islets are functionally uncoupled.
Discussion
The results described here demonstrate that Nnt plays an im-
portant role in the regulation of insulin secretion from the pan-
creatic b cell. Mice in which this protein is deleted (e.g.,
C57BL/6J) or mutated (Nnt-N68K and Nnt-G745D), are charac-
terized by impaired glucose tolerance. This is a consequence of
impaired ATP production in response to glucose elevation,
which translates into a marked decrease in insulin secretion.
Furthermore, siRNA silencing of Nnt in insulin-secreting MIN6
cells abolishes the glucose-dependent increase in both [Ca2+]i
and insulin secretion. However, both are elicited when the sul-
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ACELL METABOLISM : JANUARY 2006phonylurea tolbutamide is used to close KATP channels. These
results are consistent with the idea that metabolic regulation
of KATP channel activity is impaired in Nnt mutant mice, or fol-
lowing Nnt knockdown in the insulin-secreting MIN6 cell line.
They are also harmonious with the location of Nnt in the inner mi-
tochondrial membrane.
Role of Nnt
Two functional roles have been proposed for Nnt: the detoxifica-
tion of reactive oxygen species (Hoek and Rydstrom, 1988; Ark-
blad et al., 2005) and regulation of isocitrate dehydrogenase ac-
tivity (Sazanov and Jackson, 1994). Our results suggest that the
former may be of primary importance for the mechanism by
which loss of Nnt function impairs glucose-dependent ATP pro-
duction and insulin secretion.
Reactive oxygen species (such as superoxide) are produced
by electron leakage during mitochondrial metabolism primarily
at Complexes I and III (Raha and Robinson, 2000). A significant
fraction (at least 50%) of the superoxide generated is released
into the mitochondrial matrix (Muller et al., 2004) and as it is
membrane impermeant must be detoxified within the mitochon-
drion itself. This is achieved by conversion to H2O2 by manga-
nese-dependent superoxide dismutase 2 (SOD2) and subse-
quent oxidation to water by the glutathione cycle (Figure 7).
This process requires a continuous supply of NADPH. In mito-
chondria, this is provided by nicotinamide nucleotide transhy-
drogenase, which converts NADP+ and NADH into NADPH
and NAD+. Thus, in the absence of Nnt, one might expect an in-
crease in the concentration of H2O2 and other reactive oxygen
species.
We observed that glucose stimulated a small increase in ROS
in wild-type b cells. This is consistent with multiple previous
studies showing that the rate of ROS production is enhanced
as metabolism increases (Krauss et al., 2003; Bindokas et al.,
2003; Fridlyand and Philipson, 2004), although this has been
contested (Martens et al., 2005). Importantly, we found that
ROS production was greatly enhanced in Nnt mutant b cells,
consistent with a role for Nnt in ROS detoxification.
Several studies have shown that ROS, such as H2O2, inhibit
insulin secretion (Maechler et al., 1999; Krippeit-Drews et al.,
1999). This results from depolarization of the b cell mitochondrial
membrane potential, which inhibits ATP production and pro-
motes activation of KATP channel currents, plasma membrane
hyperpolarization, and inhibition of secretion (Maechler et al.,
1999; Krippeit-Drews et al., 1999). The mechanism by which
ROS influence the mitochondrial membrane potential and ATP
CT
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A R T I C L EFigure 5. Plasma glucose and insulin dynamics in
wild-type and Nnt mutant mice
A and B) Plasma glucose dynamics measured in re-
sponse to an intraperitoneal glucose tolerance test
(IPGTT) following overnight fasting for 12-week-old
male mice. The IPGTT was carried out over 2 hr.
Data points indicate the mean 6 SD. (A) wild-type
(circles, n = 9), heterozygous (squares, n = 10), and
homozygous (triangles, n = 15) mice carrying the
N68K mutation in Nnt. (B) wild-type (circles, n =
10), heterozygous (squares, n = 16), and homozy-
gous (triangles, n = 13) mice carrying the G745D mu-
tation in Nnt. Statistical significance of homozygote
versus wild-type and heterozygotes versus wild-
type is indicated, *p < 0.05 and **p < 0.01 (Student’s
t test).
C–F) Plasma glucose (C and D) and insulin (E and F)
dynamics measured in response to an IPGTT at 16
weeks for the same mice as in (A and B). The IPGTT
was carried out over 30 min. For key, see (A and B).
Data points indicate the mean 6 SD.
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production is believed to involve activation of uncoupling protein
2 (UCP2), since UCP2 activity is stimulated by ROS (Echtay
et al., 2002; Krauss et al., 2003; Brand et al., 2004). This leads
to enhanced proton leakage across the inner mitochondrial
membrane, reducing the electromotive force and thereby ATP
production. Consequently, increased UCP2 activity impairs
insulin secretion (Krauss et al., 2003; Chan et al., 2001) and
reduced UCP2 activity increases insulin release (Zhang et al.,
2001).
The combination of increased glucose utilization and reduced
ATP production found forNntG745D islets is consistent with the
idea that their b cell mitochondria become increasingly un-
coupled when glucose is elevated. This is predicted if the in-
creased ROS production we observed at high glucose stimu-
lates UCP2. We therefore propose that the inability of glucose
to elevate ATP in Nntmutant islets is mediated by ROS-induced
activation of UCP2 (Figure 7). Because glucose does not in-
crease ATP levels, KATP channels remain open, keeping the
membrane hyperpolarized and inhibiting insulin secretion.
Since more than 95% of ATP in the b cell is produced by the
mitochondria, and mitochondrially generated ATP is of primary
importance for insulin release (Silva et al., 2000); Maechler and
Wollheim, 2001), small changes in ROS detoxification by Nnt
might have a significant effect on insulin secretion. This idea is
consistent with the fact that male (but not female) C57BL/6J
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to oxidative stress and show more severely impaired glucose
tolerance than female mice (Friesen et al., 2004).
It has also been suggested that Nnt may exert a fine control of
flux through the tricarboxylic acid cycle, by regulating the activ-
ity of isocitrate dehydrogenase (ICD) (Sazanov and Jackson,
1994). This is because NAD+ (produced by Nnt) is required for
the activity of ICD. However, this mechanism seems less likely
to be primarily responsible for the effects of Nnt knockdown,
since reduced NAD+ production would be predicted to impair
glucose metabolism, whereas we observed glucose utilization
was enhanced.
Nnt ENU mutant mice
Both of our mutant mouse models of Nnt were significantly glu-
cose intolerant and had impaired insulin secretion. In this re-
spect, the phenotype was similar to that found for C57BL/6J
mice, which have a 5-exon deletion in Nnt (Toye et al., 2005).
ENU mutagenesis introduces multiple mutations in the genome
and with a per locus mutation rate of 0.00108 and 30,000 genes,
there will be an estimated 32 dominant functional mutations per
F1 founder mouse (Quwailid et al., 2004; Coghill et al., 2002).
These mutations are segregated by subsequent backcrossing
and, ultimately, intercrossing. The two ENU Nnt mutations we
identified were independently derived and are thus extremelyCELL METABOLISM : JANUARY 2006
Nnt and insulin secretionFigure 6. Effects of Nnt mutations on properties of islet cells
A) Insulin secretion from islets isolated from G745D Nntmice in response to glucose (0, 2, 10 mM) or tolbutamide (tol, 200 mM). Islets were isolated from two mice of each
type for these experiments. The data indicate the mean6 SD of six replicates (each of five islets) and are representative of two separate experiments on G745D mice and
two on N68K mice. Black bars represent homozygous mutants, hatched bars represent heterozygotes, and white bars represent wild-type littermates.
B)ATP content of islets isolated fromG745DNntmice in response to glucose (2mMgray bars, 20mMblack bars). Data are normalized to protein content. The data indicate
the mean 6 SEM of five replicates (each of six islets) and are representative of two separate experiments on G745D mice.
C) ROS measured using the fluorescent dye DCF in single b cells isolated from wild-type mice (white bars) and homozygous Nnt G745D mutant mice (black bars). Data
indicate the mean6 SEM of 30–50 cells at each glucose concentration (pooled data from three separate experiments). Inset: representative images of DCF fluoresecence
in b cells isolated from wild-type and G745D mutant mice incubated in 0 or 20 mM glucose.
D)Glucose utilization measured at different glucose concentrations for wild-typemice (white bars) and homozygous G745DNntmutant mice (black bars).The data indicate




unlikely to share any ENU-induced mutations in genes other
than Nnt. Furthermore, neither allele is found in the parental
strains. Thus, the observed phenotypes are due to the Nnt mu-
tations carried by the two lines.
Both homozygous Nntmutations appear to have a greater ef-
fect on glucose tolerance than that observed for C57BL/6J
mice, yet QTL mapping suggested that Nnt contributed <10%
of the glucose intolerant phenotype of C57BL/6J mice (Toye
et al., 2005). The ENU mutations are on a BALB/c background
and have been backcrossed to C3H/HeH and then intercrossed
to produce homozygous animals. In contrast, the QTL mapping
was performed between C57BL/6J and C3H/HeH in an F2 inter-
cross. Thus the genetic composition of the mice is different. The
smaller variance seen in the QTL mapping studies could be ex-
plained if C57BL/6J mice possessed compensatory mecha-
nisms that reduced the severity of the Nnt deletion. The effect
of genetic background on phenotype is well established: one
example is the ob/ob mutation that shows large differences in
diabetes susceptibility on BTBR and C57BL/6J genetic back-
grounds (Stoehr et al., 2000). QTL mapping may also underesti-
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titative trait because the effect is estimated in a genetically
heterogeneous F2 population using linked genetic markers.
Furthermore, in an F2 population, new gene interactions may be
unmasked (Stoehr et al., 2000). Thus, the phenotype of the F2
generation may differ from that observed on the original (or in-
deed other) genetic backgrounds. This may explain why Nnt
and C57BL/6Jmice have a similar phenotype despite QTLmap-
ping suggesting Nnt is only a minor contributor to the C57BL/6J
phenotype.
There was no significant difference in phenotype between the
heterozygousandhomozygousNntmice for theG745Dmutation.
Likewise, there was no difference in ATP generation or insulin
secretion between heterozygous and homozygous animals. Be-
cause Nnt functions as a homodimer (Hoek and Rydstrom,
1988), this might be due to a dominant-negative effect in which
the presence of a mutant subunit in the homodimer impairs the
function of the other subunit, thus inactivating thewhole dimer.Al-
ternatively it may be due to a gene dosage effect (i.e., >50% of
functionalprotein is required toproduce thewild-typephenotype).41
A R T I C L EFigure 7. Suggested mechanism for the effects of Nnt mutations
The activity of the electron transport chain leads to a proton gradient across the inner mitochondrial membrane that is used to drive the production of ATP by ATP synthase.
Consequently, proton leakage through uncoupling protein 2 (UCP2) decreases ATP production. UCP2 is activated by reactive oxygen species (ROS), such as O2
, gen-
erated by the electron transport chain. In b cell mitochondria of control mice, ROS are first reduced to H2O2 by mitochondrial superoxide dismutatase (SOD2), and then to
water, using reducing equivalents supplied by the glutathione couple (GSSG-GSH) and the reduction of NADP+ to NADPH by nictotinamide nucleotide transhydrogenase
(NNT). Loss of NNT function is therefore predicted to increase ROS, activate UCP2, and so reduce ATP production and insulin secretion.
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DWhy is the defect only seen in b cells?
Although Nnt is widely expressed (Arkblad et al., 2002), it ap-
pears that only the b cell is particularly sensitive to mutation
deletion of the Nnt gene as mice carrying Nnt mutations
do not suffer from any obvious problems other than glucose in-
tolerance. Strikingly the C57BL/6J strain has been widely used
for decades without the deficiency in Nnt being phenotypically
obvious (although, of course, we do not know when it arose in
the stock). The lack of an extra-pancreatic phenotype is not be-
cause of redundancy, since there is only one copy of the gene
in the genome and no other protein has been proposed to serve
a similar role. A possible explanation may be that the b cell is
particularly sensitive to small changes in cytosolic ATP, per-
haps because its metabolism has evolved to be very sensitive
to blood glucose levels. Furthermore, the b cell resting potential
is largely determined by the activity of the KATP channel (Ash-
croft and Rorsman, 1989, 2004). Small changes in KATP cur-
rents may have marked effects on insulin secretion, as evi-
denced by the effects of mutations in Kir6.2, the pore-forming
subunit of this channel (Sakura et al., 1995), in both human pa-
tients with neonatal diabetes (Gloyn et al., 2004; Proks et al.,
2004) and in transgenic mice (Koster et al., 2000). Although
Kir6.2 is expressed in multiple tissues (Sakura et al., 1995), ex-
cept for the most severe mutations, no functional effects are
manifest in tissues other than the b cell. Thus the effects of
small changes in ATP production (rather than ATP sensitivity)
produced by impaired Nnt function may be largely confined
to the b cell.
Physiological relevance for type 2 diabetes
Compared to control islets, type 2 diabetic islets have reduced
glucose oxidation and insulin secretion (Del Guerra et al., 2005).
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sion of GLUT1, GLUT2, and glucokinase. However, an increase
in markers of oxidative stress, which correlates with the degree
of impairment in glucose-stimulated insulin release, has also
been observed. Interestingly, following 24 hr culture in the pres-
ence of 30 mM glutathione, the secretory response of type 2 di-
abetic islets to glucose improved significantly (Del Guerra et al.,
2005). Thus an underlying metabolic defect, resulting in in-
creased oxidative stress, may contribute to impaired insulin se-
cretion in human type 2 diabetic patients (see also Green et al.,
2004). Given the effects of impaired Nnt function in mice, it
would clearly now be worth screening human patients to deter-
mine if polymorphisms in the Nnt gene are associated with type
2 diabetes. Furthermore, the key role of Nnt in ROS detoxifica-
tion, and the fact that insulin secretion is abolished when this
gene is mutated or deleted, suggests that drugs which enhance
Nnt function or expression might provide a valuable new strat-
egy for treating type 2 diabetes.
Experimental procedures
Animal husbandry
Mice were kept in accordance with UK Home Office welfare guidelines and
project license restrictions under controlled light (12 hr light and 12 hr dark
cycle), temperature (21ºC 6 2ºC) and humidity (55% 6 10%) conditions.
They had free access to water (25 ppm chlorine) and were fed ad libitum
on a commercial diet (SDS maintenance chow) containing 2.6% saturated
fat.
Genetic crosses
The Harwell ENU-DNA archive (Quwailid et al., 2004) was screened and two
ENU-induced point mutations on Nnt were identified by denaturing high per-
formance liquid chromatography (dHPLC) using a Transgenomic WAVE
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Nnt and insulin secretionsystem. These mice were rederived by IVF from frozen sperm using C3H/
HeH eggs, and the progeny intercrossed to produce mice homozygous for
eachmutation. Genomic DNA was extracted from the mouse tail tissue using
a Qiagen DNeasy tissue kit. Mice were genotyped by pyrosequencing. Pri-
mers were designed from published records (Arkblad et al., 2001) using Py-
rosequencing Assay Design software from Biotage. The pyrosequencing re-
sults were analyzed using the Pyrosequencer PSQ HS 96A system.
Intraperitoneal glucose tolerance tests
Mice were fasted overnight, weighed, and a blood sample collected by tail
venipuncture under local anesthetic (Lignocaine) using Lithium-Heparin mi-
crovette tubes (Sarstedt) to establish a baseline glucose level ‘‘T0’’. They
were then injected intraperitoneally with 2 g glucose (20% glucose in 0.9%
NaCl)/kg body weight and blood samples taken at the designated times.
For a fuller protocol, see EMPReSS (the European Mouse Phenotyping Re-
source for Standardized Screens designed by Eumorphia) simplified IPGTT
(http://empress.har.mrc.ac.uk). Plasma glucose was measured using an
Analox Glucose analyser GM9. Plasma insulin was measured using a Mer-
codia Ultra-Sensitive Mouse ELISA kit according to the manufacturer’s in-
structions.
MIN6 cell culture
MIN6 cells (starting passage 40) were maintained in DMEM containing
25 mM glucose and supplemented with 15% heat-inactivated fetal bovine
serum in humidified 7% CO2, 95% air at 37ºC. Cells were exposed to
glucose-free extracellular solution for 30 min prior to measurement of insulin
secretion or intracellular calcium.
Islet and b cell isolation
Mice were killed by cervical dislocation, the pancreas removed, and islets
isolated by liberase digestion and handpicking (Toye et al., 2005). Isolated is-
lets were dispersed into single cells by incubation in calcium-free Hank’s
solution (1 mM EGTA) and trituration in RPMI tissue culture medium contain-
ing 5.5mMglucose (Gibco, UK) supplementedwith 10% fetal calf serum, 100
U/ml penicillin, and 100mg/ml streptomycin. Cells were maintained in this
medium at 37ºC in a humidified atmosphere at 5% CO2 in air, and used
1–2 days after the isolation.
siRNA
Synthetic siRNAs were designed by Eurogentec and synthesized by both
Eurogentec and VH Bio Ltd. A total of four siRNAs were used; Nonsense
(NS), Glucokinase (Gck), and two Nnt siRNAs. Each siRNA had a Cy3 tag
on the 50 end of the sense strand to enable visualization of transfected cells.
siRNA duplexes (5 nM) were transfected into MIN6 cells using Lipofectamine
2000 (Invitrogen) at 200 nM. Cells were cultured in DMEM (FBS-free) for a fur-
ther 24 hr before experiment.
Quantitative RT-PCR
Total RNA from siRNA-transfected MIN6 cells was extracted using RNeasy
mini-kit (Qiagen). cDNA generated by Superscript II enzyme (Invitrogen)
was analyzed by RT-PCR using a SYBR green PCR kit and an ABIPRISM
7700 Sequence detector (Perkin Elmer). To quantitate Nnt expression, it
was PCR amplified from cDNA together with Gapdh (glyceraldehyde-3-
phosphate dehydrogenase) as an endogenous control. All data were normal-
ized to Gapdh expression. RT-PCR primers listed in 50 to 30 orientation are:
For Gapdh:Gapdh888F: CCTGCGACTTCAACAGCAACT andGapdh979RV:
CCAGGAAATGAGCTTGACAAA; For Nnt: NntXn5inF: GATAGTTGGTGGTG
GAGTTG and NntXn6inR: GATGTCCACCTCCTTGCACT.
The t tests for significant differences between strains are based on RQ
(Nnt/Gapdh) values.
Protein gels and Western blot analysis
Target-specific gene knockdown was verified using SDS-PAGE 12%gel and
Western blot. Protein samples were heated for 3 min at 100ºC in sample
buffer (final concentration of 30 mM Tris-HCl [pH 6.8], 5% glycerol,
0.005% bromophenol blue, 2.5% b-mercaptoethanol). Proteins were size-
separated by electrophoresis alongside a ‘‘SeeBlue’’ (Invitrogen) protein lad-
der to allow molecular weights to be estimated.
Proteins were transferred to Hybond-P membrane (Amersham) using
a Transblot SD system (Biorad) by passing 100V across membrane/gel for
ET
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(raised against peptides, Eurogentec), Gck antibody, and actin antibody
(control) from Santa Cruz. ECL plus (Amersham) was then used according
to manufacturer’s instructions to allow visualization of protein on ECL film,
developed using the Compact X4 (Xograph).
Fura-2 calcium imaging
MIN6 cells were cultured on 35 mm Fluorodishes (World Precision Instru-
ments) and incubated with DMEM plus 3 mM Fura-2-AM (Molecular Probes)
for 40 min at 37ºC. They were imaged at room temperature (20ºC –24ºC) us-
ing an IonOptix fluorescence system (Boston, Massachusetts), with 340 nm
and 380 nm dual excitation. The 510 nm emission ratio was collected at 1 Hz.
Background subtraction was performed by measuring fluorescence from
a cell-free region in the field of view. Cells were perfused continuously with
extracellular solution containing (mM): 137 NaCl, 5.6 KCl, 2.6 CaCl2, 1.2
MgCl2, 10 HEPES (pH 7.4 with NaOH) plus glucose or tolbutamide as indi-
cated. Only data from cells that responded for 30 min prior to addition of
500 mM tolbutamide were analyzed.
Insulin secretion
MIN6 cells (13 105) were replated, transfectedwith various siRNA’s, and cul-
tured for 24 hr (as above) before being used in secretion assays. Islets were
isolated from wild-type and mutant mice and cultured overnight in PIM
medium (l-cell technology, Nevada) before insulin secretion was assessed.
Insulin secretion was measured during 1 hr static incubations in Krebs-
Ringer Buffer (KRB solution; in mM: 118.5 NaCl, 2.54 CaCl2, 1.19 KH2PO4,
4.74 KCl, 25 NaHCO3, 1.19 MgSO4, 10 HEPES, [pH 7.4]) containing 0, 2, or
10mMglucose or 0.2mM tolbutamide. Each glucose concentration was rep-
licated five to eight times. Samples of the supernatant were assayed for
insulin. To determine total insulin content, insulin was extracted using 95:5
ethanol/acetic acid. Insulin was measured using a Mouse Insulin ELISA kit
(Mercodia, Sweden).
ATP measurements
Batches of six islets were incubated at 37ºC for 1 hr in 50 ml KRB solution con-
taining 2 mg/ml BSA and various concentrations of glucose. After this time,
25 ml of ice-cold 10% perchloric acid was added and islets were disrupted
by vortexing for 10 s. Each glucose concentration was tested in five separate
assays, and ATP was measured in duplicate in 10 ml aliquots from each as-
say, using a luciferin-luciferase bioluminescent assay (Sigma St Louis, Mis-
souri) and a TD20/20 luminometer (Turner Designs, Sunnyvale, California).
Protein content was measured the DC protein assay kit (BioRad, Hercules,
California). ATP content was normalized to protein content to correct for dif-
ferences in islet size.
Glucose utilization measurements
Glucose utilization was determined as the formation of [3H]water from
[5-3H]glucose. After overnight culture in PIM medium, batches of five islets
were incubated at 37ºC for 2 hr in 10 ml of KRB solution containing [5-3H]glu-
cose at various concentrations of glucose, as described by (Ashcroft et al.,
1972). Control samples containing no islets were included to allow for correc-
tion for [3H]water in [3H]glucose. Glucose utilization rates were calculated as
pmol of glucose utilized/hour/islet from: Glucose utilized (pmol) = [3H]water
formed (c.p.m)/specific radioactivity of [5-3H]glucose (c.p.m./pmol).
Measurement of reactive oxygen species
A 10 mM stock solution of H2DCFDA-SE (2
0,70-dichlorofluorescein diacetate
with a succinimidyl ester group, Molecular Probes) was prepared in DMSO,
stored at270ºC, and diluted with KRB (pH 7.0) just before use to a final con-
centration of 10 mM. b cells were plated in 24-well cell culture plates over-
night. They were then washed twice with PBS, incubated in PBS plus DCF
for 30 min at 37ºC, washed with PBS, and incubated in KRB containing
0 or 20 mM glucose for a further 30 min. They were imaged at room temper-
ature using an IonOptix fluorescence system (Boston, Massachusetts), with
495 nm excitation and 520 nm emission. The background fluorescence was
subtracted. We used 0.5 mMmenadione as a generator of ROS as a control:
we observed no difference in fluorescence between wild-type and Nnt
mouse b cells exposed to menadione, indicating that there were no differen-
ces in dye loading between wild-type and mutant b cells.
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Supplemental Data include three figures and Supplemental Experimen-
tal Procedures and can be found with this article online at http://www.
cellmetabolism.org/cgi/content/full/3/1/35/DC1/.
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